Skip to main content

Jun Won Kim

Yonsei University · 医学

研究室紹介

Professor Jun Won Kim's research lab focuses on translational oncology and molecular pharmacology, with a strong emphasis on improving cancer treatment outcomes through innovative radiotherapy techniques, systemic therapies, and biomarker discovery. The lab investigates organ-preserving strategies in head and neck cancers, explores adjuvant therapies for metastatic colorectal and rectal cancers, and delves into the biological mechanisms of sarcopenia and treatment-related toxicity. Additionally, the lab contributes to antiviral drug discovery, particularly in the development of novel non-nucleoside reverse transcriptase inhibitors for HIV. These multidisciplinary efforts reflect a commitment to enhancing patient survival and quality of life through precision medicine and targeted therapeutic interventions.

esophageal cancersarcopeniaSBRTcolorectal cancerHIV drug discovery

Research Overview

Papers
218
Total Citations
5,515
Papers (5y)
52
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
52total
2022
2023
2024
2025
2026
Citations per year (5y)
157total
20222023202420252026

Selected Papers

15
1
Article|57 citations·2012
A Multimodal Approach Including Craniospinal Irradiation Improves the Treatment Outcome of High-risk Intracranial Nongerminomatous Germ Cell Tumors
Jun Won Kim, Woo Chul Kim, Jaeho Cho, Dong-Seok Kim, Kyu‐Won Shim, Chuhl Joo Lyu, Sung Chul Won, Chang‐Ok Suh
SJR Q1International Journal of Radiation Oncology*Biology*Physics
GeneticsMedicine
2
Article|50 citations·2018
Phase I/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma
Jun Won Kim, Do Young Kim, Kwang‐Hyub Han, Jinsil Seong
SJR Q1Digestive and Liver DiseaseOA
HepatologyMedicine
3
Article|48 citations·2016
Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
Jun Won Kim, Jinsil Seong, Ik Jae Lee, J.Y. Woo, Kwang‐Hyub Han
SJR Q2OncotargetOA

Helical IMRT-based SBRT was tolerable and showed encouraging results. Confirmatory phase II trial is underway.

RadiationPhysics and Astronomy
4
Article|45 citations·2015
Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer
Jun Won Kim, Mi Sun Kim, Se‐Heon Kim, Joo Hang Kim, Chang Geol Lee, Gwi Eon Kim, Ki Chang Keum
SJR Q1Cancer Research and TreatmentOA

Organ preserving CRT provided a treatment outcome that is comparable to SRT for locally advanced hypopharyngeal cancer, while offering an opportunity for functional larynx-preservation and reduced treatment-related toxicity.

OtorhinolaryngologyMedicine
5
Article|38 citations·2010
The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study
Jun Won Kim, Yong Bae Kim, Nam Kyu Kim, Byung-Soh Min, Sang Joon Shin, Joong Bae Ahn, Woong Sub Koom, Jinsil Seong, Ki Chang Keum
SJR Q1Radiation OncologyOA

BACKGROUND: Synchronous liver metastases are detected in approximately 25% of colorectal cancer patients at diagnosis. The rates of local failure and distant metastasis are substantial in these patients, even after undergoing aggressive treatments including resection of primary and metastatic liver tumors. The purpose of this study was to determine whether adjuvant pelvic radiotherapy is beneficial for pelvic control and overall survival in rectal cancer patients with synchronous liver metastasi

HepatologyMedicine
6
Article|33 citations·2012
Discovery of Phenylaminopyridine Derivatives as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
Jun Won Kim, Doohyun Lee, Changmin Park, Wonyoung So, Mina Jo, Taedong Ok, Jeongjin Kwon, Sunju Kong, Suyeon Jo, Young Mi Kim, Jihyun Choi, Hyoung Cheul Kim
SJR Q1ACS Medicinal Chemistry LettersOA

We identified a novel class of aryl-substituted triazine compounds as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) during a high-throughput screening campaign that evaluated more than 200000 compounds for antihuman immunodeficiency virus (HIV) activity using a cell-based full replication assay. Herein, we disclose the optimization of the antiviral activity in a cell-based assay system leading to the discovery of compound 27, which possessed excellent potency against wild-type

Infectious DiseasesMedicine
7
Article|32 citations·2019
Relationship Between Sarcopenia and Prognosis in Patient With Concurrent Chemo-Radiation Therapy for Esophageal Cancer
Daeyoun David Won, Yeona Cho, Mi-jin Jeon, Jie‐Hyun Kim, Jie-Hyun Kim, Ik Jae Lee, Young Hoon Youn, Jae Jun Park, Da Hyun Jung, Hyojin Park, Chang Geol Lee, Jun Won Kim
SJR Q2Frontiers in OncologyOA

Background: Sarcopenia, defined as skeletal muscle loss, has been known as a poor prognosis factor in various malignant diseases. The aim of this study is to investigate the effect of sarcopenia on prognosis in patients with esophageal cancer who received concurrent chemo-radiation therapy(CCRT). Methods: We retrospectively collected clinical data of 287 patients with esophageal cancer who were treated by definite CCRT at Gangnam Severance and Severance hospital from August 2005 to December 2014

PhysiologyMedicine
8
Article|27 citations·2011
Usefulness of Positron Emission Tomography With Fluorine-18-Fluorodeoxyglucose in Predicting Treatment Response in Unresectable Hepatocellular Carcinoma Patients Treated With External Beam Radiotherapy
Jun Won Kim, Jinsil Seong, Mijin Yun, Ik Jae Lee, Hong In Yoon, Hojin Cho, Kwang‐Hyub Han
SJR Q1International Journal of Radiation Oncology*Biology*Physics
HepatologyMedicine
9
Article|27 citations·2001
Properties of the Corynebacterium glutamicum metC Gene Encoding Cystathionine β-lyase
Jun Won Kim, Hyung Joon Kim, Younhee Kim, Myeong‐Sok Lee, Heung-Shick Lee
SJR Q1Molecules and CellsOA

The metC gene encoding the cystathionine β-lyase, the third enzyme in the methionine biosynthetic pathway, was isolated from Corynebacterium glutamicum by heterologous complementation of the Escherichia coli metC mutant. A DNA-sequence analysis of the cloned DNA identified two open-reading frames (ORFs) of ORF1 and ORF2 that consisted of 1,107 and 978 bp, respectively. A SDS-PAGE analysis identified a putative cystathionine β-lyase band with approximate Mr of 41,000 that consisted of 368 amino a

BiochemistryBiochemistry, Genetics and Molecular Biology
10
Article|26 citations·2012
Cdc5-Dependent Asymmetric Localization of Bfa1 Fine-Tunes Timely Mitotic Exit
Jun Won Kim, Guangming Luo, Young Yil Bahk, Kiwon Song
SJR Q1PLoS GeneticsOA

In budding yeast, the major regulator of the mitotic exit network (MEN) is Tem1, a GTPase, which is inhibited by the GTPase-activating protein (GAP), Bfa1/Bub2. Asymmetric Bfa1 localization to the bud-directed spindle pole body (SPB) during metaphase also controls mitotic exit, but the molecular mechanism and function of this localization are not well understood, particularly in unperturbed cells. We identified four novel Cdc5 target residues within the Bfa1 C-terminus: (452)S, (453)S, (454)S, a

Cell BiologyBiochemistry, Genetics and Molecular Biology
11
Article|26 citations·2018
Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapy
Jun Won Kim, Tae Hyung Kim, Jie‐Hyun Kim, Ik Jae Lee
SJR Q1World Journal of GastroenterologyOA

Chemoradiation for CEC was well tolerated, and a higher dose was not associated with stenosis. Patients with complete circumferential involvement require close follow-up.

SurgeryMedicine
12
Article|25 citations·2013
Development of a porcine skin injury model and characterization of the dose-dependent response to high-dose radiation
Jun Won Kim, Dong Won Lee, Won Hoon Choi, Yeo Reum Jeon, Se Hoon Kim, Haemi Cho, Dong Won Lee, Zhenyu Hong, Won Jai Lee, Jaeho Cho
SJR Q2Journal of Radiation ResearchOA

A porcine skin model was developed to characterize the dose-dependent response to high-dose radiation. The dorsal skin of a mini pig was divided into four paraspinal sections, with 11 small irradiation fields (2 cm × 2 cm) in each section, and a single fraction of 15, 30, 50 or 75 Gy was delivered to each section using a 6 MeV electron beam. A spectrophotometer measured gross skin changes, and a biopsy for each radiation dose was performed in the 1st, 2nd, 4th, 6th and 9th weeks for histology, i

Radiology, Nuclear Medicine and ImagingMedicine
13
Article|23 citations·2016
Maximum surgical resection and adjuvant intensity-modulated radiotherapy with simultaneous integrated boost for skull base chordoma
Jun Won Kim, Chang‐Ok Suh, Chang‐Ki Hong, Eui Hyun Kim, Ik Jae Lee, Jaeho Cho, Kyu‐Sung Lee
SJR Q1Acta NeurochirurgicaOA
RheumatologyMedicine
14
Article|21 citations·2012
Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors
Jun Won Kim, Jeongjin Kwon, Doohyun Lee, Suyeon Jo, Dong‐Sik Park, Jihyun Choi, Eun‐Jung Park, Jong Yeon Hwang, Yoonae Ko, Inhee Choi, Moon Kyeong Ju, Jiye Ahn
SJR Q2Bioorganic & Medicinal Chemistry Letters
VirologyImmunology and Microbiology
15
Article|20 citations·2018
High‐dose versus standard‐dose radiation therapy for cervical esophageal cancer: Retrospective single‐institution study
Tae Hyung Kim, Ik Jae Lee, Jie‐Hyun Kim, Ji‐Hyun Kim, Chang Geol Lee, Yong Chan Lee, Jun Won Kim, Jun Won Kim
SJR Q1Head & NeckOA

BACKGROUND: To evaluate the role of definitive radiotherapy using higher-than-standard-dose radiation of 50 Gy for carcinoma of the cervical esophagus (CCE). METHODS: We reviewed 79 patients with stage I-III CCE, treated between 2000 and 2012. Patients received 5-fluorouracil/cisplatin-based chemotherapy concurrently and were divided into high-dose (≥59.4 Gy, n = 44) and standard-dose (<59.4 Gy, n = 35) groups. RESULTS: The median follow-up was 35 months for surviving patients. The high-dose gro

SurgeryMedicine

Research Areas

HepatologyPulmonary and Respiratory MedicineOtorhinolaryngologyRadiationSurgeryCancer Research

Jun Won Kimの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。